The nanoparticle measurement instrument market size is projected to reach US$ 10.93 billion by 2031 from US$ 7.59 billion in 2023. The market is expected to register a CAGR of 4.7% during 2023–2031. The integration of artificial intelligence and machine learning is likely to act as a future trend in the market.
The expanding applications of nanotechnology and developments in analytical techniques are driving the nanoparticle measurement instrument market toward growth. Nanoparticles are small particles with diameters ranging from 1 to 100 nm. Instruments such as transmission electron microscopes (TEM), scanning electron microscopes (SEM), atomic force microscope (AFM), and X ray diffractometers are used for determining the particle concentration and particle size. They are also used in techniques such as dynamic light scattering and microscopy. In recent years, nanoparticles have gained attention due to their use in consumer products, medicine, soil, and aquatic environments, which signifies the need for instruments to measure their sizes and study their characteristics.
China is expected to register the highest CAGR in the Asia Pacific nanoparticle measurement instruments market during the forecast period. The presence of renowned research organizations such as the National Center for Electron Microscopy in Beijing and the Chinese National Protein Science Facility at Tsinghua University, along with research facilities of private companies, e.g., including the Thermo Fisher Scientific electron microscopy facility located in Shanghai, China, are contributing to the market size in China. These research organizations utilize advanced analytical instruments such as SEM, TEM, and XRDs to understand the structures of nanoparticles. Moreover, companies, organizations, governments, etc., are contributing to the increasing research activities utilizing nanoparticles and the expanding use of nanoparticles in the pharmaceutical industry in China. Thus, such activities in the healthcare sector bolster the nanoparticle measurement instrument market growth in China.
Nanotechnology is being employed in a rising number of applications in the pharmaceutical industry, including cancer treatment, targeted drug delivery, and diagnostic imaging. The use of nanoparticles as drug delivery vehicles helps increase the efficacy and lower the side effects of therapeutic candidates. Nanopharmaceuticals are the materials manipulated at the nanoscale, often to produce drugs with enhanced bioavailability, controlled release properties, or targeting. These applications need precise measuring devices to monitor drug delivery, assure quality control, and characterize nanoparticles. A thorough understanding of and control over nanoparticle size, shape, surface charge, and composition are necessary to develop nanopharmaceuticals. Thus, zeta potential analyzers, electron microscopes, and size analyzers are essential for investigations related to nanoparticles. Nanopharmaceuticals can ensure the precise delivery of drugs to particular tissues or cells, along with improving their stability and solubility. The continuous research and optimization efforts in the field of nanotechnology depend on the availability of sophisticated measurement tools to understand and alter the interactions and properties at the nanoscale. Thus, an increase in the application of nanotechnology to produce nanopharmaceuticals is driving the global nanoparticle measurement instrument market growth.
Several research activities are being carried out on drug delivery using nanotechnology. Nanotechnology contributes significantly to the effectiveness and potency of chronic disease treatments through site-specific and target-oriented delivery of precise medicines in humans. Various nanomedicine agents have been studied for their application in chemotherapy and immunotherapy. Recent efforts to advance nano-based drug delivery systems and nanomedicine have been focused on improving drug delivery by using the efficacy and selectiveness of nanomaterials. The use of large-sized materials in drug delivery poses substantial challenges, which include poor bioavailability, in vivo instability, poor solubility, issues with target-specific delivery, and sub-optimal absorption within the body. Nanotechnology plays a significant role in advanced medicine/drug formulations, as their size, shape, and surface chemistry can be adjusted to deduce benefit from the unique properties of nanoscale materials and structures; this allows tailoring their functionalities for different biomedical applications. For instance, lipid nanoparticles (LNPs) are being studied by AstraZeneca as a novel and promising delivery system for nucleotide-based medicines that produce therapeutic proteins inside target cells. Creative Biolabs offers sophisticated formulation development systems for APIs. Its particle and nanoparticle engineering technologies enable an array of nanotechnology-based drug delivery platforms. The business also sells polymeric nanoparticles, liposomes, and nanocrystals. Thus, continuous developments in nanotechnology-based drug delivery systems are expected to generate significant opportunities for the nanoparticle measurement instrument market in the coming years.
Key segments that contributed to the derivation of the nanoparticle measurement instrument market analysis are products and type, application, and end user.
The geographic scope of the nanoparticle measurement instrument market report is mainly divided into five regions: North America, Asia Pacific, Europe, South & Central America, and the Middle East & Africa. North America dominated the market in 2023. The growth of the market in this region is attributed to the growing presence of companies offering nanoparticle measurement instruments, the commercialization of nanotechnology in the pharmaceutical & biotechnology industry, and increasing activities in research and development by the medical device industry. In recent years, significant progress has been made in the development of nanoparticles for various clinical applications, including disease diagnosis and treatment. For instance, when lipid-based, polymeric, and inorganic nanoparticles are engineered in increasingly specialized ways, these particles can be widely optimized for drug delivery in a personalized manner; this introduces the era of precision medicine. Owing to these emerging applications of nanoparticles in the field of healthcare, various companies in the US are launching advanced instruments to analyze nanoparticles. For instance, in July 2023, JEOL USA, Inc. launched two new SEM instruments at the Microscopy and Microanalysis (M&M) Exhibition held in Minneapolis. The JSM-IT710HR SEM is a compact, versatile Schottky Field Emission SEM, which is ideal for higher resolution needs. Also, the JSM-IT210 InTouchScope SEM features an easy, automated workflow for new operators. These SEMs incorporate JEOL intelligent technology for simple operation; fast, high-resolution imaging; and various specimen analyses, including peacock feathers, limestone particles, and polymers.
The regional trends and factors influencing the Nanoparticle Measurement Instrument Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Nanoparticle Measurement Instrument Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 7.59 Billion |
| Market Size by 2031 | US$ 10.93 Billion |
| Global CAGR (2023 - 2031) | 4.7% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Nanoparticle Measurement Instrument Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Nanoparticle Measurement Instrument Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The nanoparticle measurement instrument market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the market are listed below:
The "Nanoparticle Measurement Instrument Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:
The List of Companies - Nanoparticle Measurement Instrument Market
The nanoparticle measurement instrument market value is expected to reach US$ 10.92 billion by 2031.
The market is expected to register a CAGR of 4.7% during 2023–2031.
Bruker Corp, Spectradyne LLC, Malvern Panalytical Ltd, IZON Science LTD, Particle Metrix GmbH, Microtrac Retsch GmbH, Horiba Ltd, Angstrom Advanced Inc., Shimadzu Corp, and Yokogawa Electric Corp are among the key players in the market.
North America dominated the market in 2023.
The expanding applications of nanotechnology and advancements in analytical techniques are among the most significant factors fueling the market growth.
The integration of artificial intelligence and machine learning is expected to be a prime trend in the market in the coming years.